LSD1-IN-30

CAS No. 1289575-45-6

LSD1-IN-30( —— )

Catalog No. M37358 CAS No. 1289575-45-6

LSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 169 In Stock
10MG 271 In Stock
25MG 543 In Stock
50MG 854 In Stock
100MG 1367 In Stock
200MG 1841 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LSD1-IN-30
  • Note
    Research use only, not for human use.
  • Brief Description
    LSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia.
  • Description
    LSD1-IN-30 (compound 3) is a potent inhibitor of lysine-specific demethylase 1 (LSD1), with the IC50 value of 0.291 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    Histone Demethylase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1289575-45-6
  • Formula Weight
    270.28
  • Molecular Formula
    C15H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (369.99 mM; Ultrasonic )
  • SMILES
    C(=N\NC(=O)C1=CC=C(O)C=C1)(\C)/C2=C(O)C=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Venkataswamy Sorna, et al. High-Throughput Virtual Screening Identifies Novel N′?(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors. J Med Chem. 2013 Dec 12;56(23):9496-508.?
molnova catalog
related products
  • Vafidemstat

    Vafidemstat is a novel potent, selective lysine-specific histone demethylase (LSD1) inhibitor.

  • PFI-90

    PFI-90 is a selective inhibitor of histone demethylase (KDM3B) that inhibits PAX3-FOXO1 action.PFI-90 has the potential for the antitumor activity.

  • SNDX-5613

    SNDX-5613 is a potent and specific inhibitor of Menin-MLL(Ki of 0.149 nM and a cell based IC50 of 10-20 nM).